Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - STOCK-BASED COMPENSATION
Stock-based Compensation FATE - Fate Therapeutics, Inc.
43.5 M
LAST VALUE
-10.59%
2 YEAR CAGR
47.18%
5 YEAR CAGR
39.53%
10 YEAR CAGR